Recall · CPSC (US)

Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

Bayer HealthCare LLC, of Whippany, New Jersey·Other·April 30, 2026

Yes. Bayer HealthCare LLC, of Whippany, New Jersey's product was recalled on April 30, 2026 by CPSC (US). Reported hazard: The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children. What to do: Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.

Data updated July 21, 2026 · Source: official CPSC (US) recall data, checked every 30 minutes

Bayer Recalls 6 mL Size Afrin Original Nasal Spray Bottles Due to Risk of Serious Injury or Illness from Child Poisoning; Violates Mandatory Standard for Child-Resistant Packaging

What was recalled

This recall involves unexpired Travel Size Afrin® Original Nasal Spray 6 mL bottles, with Lot numbers 230361, 240822, 241198, 250066, 250152, 250646, and 250831. These travel size bottles have "Afrin® Original Nasal Spray" and "1/5 FL OZ (6 mL)" printed on a label located on the front of the bottle. It is a six-digit number, followed by the expiration date in following format: "YYYYMMM". No other sizes of Afrin are included in this recall.

The hazard

CPSC (US) flagged this Bayer HealthCare LLC, of Whippany, New Jersey product for the following risk:

The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.

What to do

If you own a Bayer HealthCare LLC, of Whippany, New Jersey product, here is the remedy CPSC (US) lists:

Consumers should immediately secure the recalled bottles out of sight and reach of children and go to the webform posted on www.livewell.bayer.com/afrin-original-spray-recall to begin a request for a refund. Consumers will be asked to take and submit a photo of the product before disposing of it in order to receive a refund.

Original recall notice: CPSC (US) →

Common questions

Is the Bayer HealthCare LLC, of Whippany, New Jersey product recalled?

Yes. Bayer HealthCare LLC, of Whippany, New Jersey's product was recalled on April 30, 2026 by CPSC (US). Reported hazard: The 6 mL nasal sprays contain an imidazoline, which must be in child-resistant packaging or meet the labeling requirements for non-complying packaging, as required by the Poison Prevention Packaging Act. The 6 mL nasal spray's packaging is not child-resistant nor bears the required labeling statement, posing a risk of serious injury or illness from poisoning, if the contents are swallowed by young children.

What should I do if I have this product?

Where can I read the official recall notice?

The original notice is published by CPSC (US) — linked directly from this page.

Want to hear about recalls like this without checking?

We monitor CPSC, FDA, and EU Safety Gate every 30 minutes. Recall info is always free.

One email a week. Unsubscribe anytime.

Other recalls

More other recalls Pouch has tracked. See all →